Beijing Infervision Completes D1 Funding for AI-based Image Reading Products
December 03, 2020 at 05:41 AM EST
Infervision, a Beijing company that develops AI-based imaging readers, completed a D1 financing round of undisclosed size. Founded in 2014, Infervision has launched eight programs that are fully integrated with medical workflows to aid the reading of scans. Its products are available in more than 10 countries in Asia, Europe and North America . The D1 round was led by Zhongguancun M&A Fund of Funds, with participation from Zhongguancun Science City, Shenzhen Yicun Tongsheng, Shanghai Lianyi and previous shareholders. More details.... Share this with colleagues: // //
